LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 146 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.38 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $138,000 | +13.1% | 22,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $122,000 | -8.3% | 22,000 | +10.0% | 0.00% | 0.0% |
| Q4 2018 | $133,000 | -37.6% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $213,000 | +10.9% | 20,000 | +25.0% | 0.00% | 0.0% |
| Q2 2018 | $192,000 | +47.7% | 16,000 | +5.3% | 0.00% | 0.0% |
| Q1 2018 | $130,000 | -9.7% | 15,200 | +4.1% | 0.00% | 0.0% |
| Q4 2017 | $144,000 | -19.6% | 14,600 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $179,000 | -25.4% | 14,600 | 0.0% | 0.00% | -50.0% |
| Q2 2017 | $240,000 | +14.8% | 14,600 | 0.0% | 0.00% | +100.0% |
| Q1 2017 | $209,000 | +3.5% | 14,600 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $202,000 | -23.5% | 14,600 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $264,000 | +14.3% | 14,600 | -9.3% | 0.00% | 0.0% |
| Q2 2016 | $231,000 | +20.3% | 16,100 | 0.0% | 0.00% | +100.0% |
| Q1 2016 | $192,000 | -10.3% | 16,100 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $214,000 | +39.9% | 16,100 | +12.7% | 0.00% | 0.0% |
| Q3 2015 | $153,000 | +33.0% | 14,285 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $115,000 | – | 14,285 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
| BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
| Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
| Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
| NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
| PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
| Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |